Founded in July 2016, Phanes is led by a team of industry veterans with extensive drug discovery and development experience in global pharma and biotech companies, including Pfizer, Amgen, and J&J. With extensive experience and relentless pursuit of deep science, we are well positioned to discover and advance robust therapeutic molecules for patients with cancer. In addition to a strong pipeline, we have developed disruptive technologies that enable drug discovery.